Global Pharmatech, Inc. (GBLP)
OTCMKTS
· Delayed Price · Currency is USD
0.2012
0.00 (0.00%)
May 21, 2025, 4:00 PM EDT
Global Pharmatech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
---|---|---|---|---|---|---|
Period Ending | Jun '08 Jun 30, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 |
Revenue | 3.18 | 2.82 | 2.13 | 3.09 | 1.56 | 1.72 |
Revenue Growth (YoY) | 55.57% | 32.43% | -31.00% | 98.32% | -9.60% | - |
Cost of Revenue | 1.71 | 1.5 | 0.53 | 1.4 | 0.53 | 0.22 |
Gross Profit | 1.47 | 1.32 | 1.6 | 1.69 | 1.02 | 1.5 |
Selling, General & Admin | 1.75 | 1.79 | 1.72 | 1.56 | 0.95 | 0.97 |
Research & Development | 0.72 | 0.71 | 0.69 | 0.51 | -0.39 | 0.43 |
Operating Expenses | 3.78 | 3.81 | 2.87 | 2.06 | 0.56 | 1.4 |
Operating Income | -2.31 | -2.49 | -1.28 | -0.38 | 0.46 | 0.1 |
Interest Expense | -0.23 | -0.19 | -0.14 | -0.19 | -0.13 | -0.11 |
Other Non Operating Income (Expenses) | 0.26 | 0.18 | 0.51 | 0.7 | - | 0.31 |
Pretax Income | -2.28 | -2.5 | -0.9 | 0.13 | 0.33 | 0.31 |
Income Tax Expense | - | - | - | 0 | 0.02 | 0.1 |
Earnings From Continuing Operations | -2.28 | -2.5 | -0.9 | 0.13 | 0.31 | 0.21 |
Earnings From Discontinued Operations | - | -0.85 | -0.22 | - | - | - |
Net Income to Company | -2.28 | -3.35 | -1.13 | 0.13 | 0.31 | 0.21 |
Minority Interest in Earnings | 0.04 | 0.05 | -0.11 | 0.07 | -0 | 0.09 |
Net Income | -2.24 | -3.3 | -1.23 | 0.2 | 0.31 | 0.3 |
Net Income to Common | -2.24 | -3.3 | -1.23 | 0.2 | 0.31 | 0.3 |
Net Income Growth | - | - | - | -35.28% | 3.78% | - |
Shares Outstanding (Basic) | 23 | 23 | 22 | 18 | 17 | 4 |
Shares Outstanding (Diluted) | 23 | 23 | 22 | 18 | 17 | 4 |
Shares Change (YoY) | 0.05% | 7.72% | 22.21% | 3.15% | 290.84% | - |
EPS (Basic) | -0.10 | -0.14 | -0.06 | 0.01 | 0.02 | 0.07 |
EPS (Diluted) | -0.10 | -0.14 | -0.06 | 0.01 | 0.02 | 0.07 |
EPS Growth | - | - | - | -37.26% | -73.45% | - |
Free Cash Flow | 0.04 | -0.57 | -0.15 | -2.22 | 0.19 | -1.38 |
Free Cash Flow Per Share | 0.00 | -0.03 | -0.01 | -0.13 | 0.01 | -0.32 |
Gross Margin | 46.24% | 46.69% | 75.04% | 54.62% | 65.69% | 87.38% |
Operating Margin | -72.55% | -88.39% | -59.91% | -12.29% | 29.70% | 6.05% |
Profit Margin | -70.45% | -117.02% | -57.99% | 6.50% | 19.93% | 17.36% |
Free Cash Flow Margin | 1.39% | -20.33% | -7.20% | -72.08% | 12.23% | -80.44% |
EBITDA | -1.81 | -2.08 | -0.74 | 0.15 | 0.88 | 0.42 |
EBITDA Margin | -57.03% | -73.63% | -34.62% | 4.90% | 56.48% | 24.33% |
D&A For EBITDA | 0.49 | 0.42 | 0.54 | 0.53 | 0.42 | 0.31 |
EBIT | -2.31 | -2.49 | -1.28 | -0.38 | 0.46 | 0.1 |
EBIT Margin | -72.55% | -88.39% | -59.91% | -12.29% | 29.70% | 6.05% |
Effective Tax Rate | - | - | - | 0.90% | 5.35% | 31.24% |
Advertising Expenses | - | 0.3 | 0.07 | 0.17 | 0.02 | 0.1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.